CWM
DCPH

Compass Wealth Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Compass Wealth Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,250
Closed -$66.9K – 403
2024
Q1 		$66.9K Hold
4,250
– – 0.02% 225
2023
Q4 		$68.6K Hold
4,250
– – 0.02% 219
2023
Q3 		$54.1K Hold
4,250
– – 0.02% 228
2023
Q2 		$59.8K Hold
4,250
– – 0.02% 230
2023
Q1 		$65.7K Hold
4,250
– – 0.02% 215
2022
Q4 		$69.7K Buy
+4,250
New +$69.1K 0.02% 206

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Compass Wealth Management's DCPH Position: Q2 2024 in Review

Compass Wealth Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 4,250 shares — an estimated $66.9K sold.

Compass Wealth Management first reported a position in DCPH in Q4 2022 and held it in 6 quarters. The position peaked at $69.7K in Q4 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Compass Wealth Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Compass Wealth Management sold 4,250 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $66.9K.
  • Compass Wealth Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Compass Wealth Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $69.7K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Compass Wealth Management's 13F filing for Q2 2024, filed 16 Jul 2024.